Steroids and opioid receptors

https://doi.org/10.1016/0960-0760(94)90080-9Get rights and content

Abstract

The genomic mode of action is believed to represent the predominant effect of a steroid hormone. Recently, however, rapidly manifesting, non-genomic effects have also been observed. These are mediated mostly by allosteric interaction of a steroid with heterologous target structures such as membrane receptors, a prototype example being the GABAA. Here we describe our studies considering two interdependent questions: (1) do steroids also interact with opioid receptors in brain? Twenty different steroids, i.e. estrogens, androgens, glucocorticoids, mineralocorticoids, gestagens and a cardiac glycoside were tested with respect to their ability to compete for in vitro binding to rat brain membranes of 3H-ligands specific for σ, μ and κ opioid receptors, respectively. Among all classes of steroids, only the estrogens were effective, all others were 20 to 100 times less effective or ineffective. The rank order among the estrogens was diethylstilbestrol > 17α-estradiol > 17α-ethinyl-estradiol > estriol > estrone > 17β-estradiol. Next potent to estrogens (although far less) were—on average as a group—glucocorticoids, followed by mineralocorticoids, androgens, gestagens and digoxin. This global as well as within-group rank order was, with rare exceptions, qualitatively equal irrespective of which radioligand was used, yet displayed the various radioligands different sensitivities with respect of being inhibited by steroids (irrespective of kind), i.e. in the order [3H]naloxone ⩾ [3H]DAGO ⩾ [3H]DADL > [3H]DPDP ⪢ [3H]etorphine. The IC50 of diethylstilbestrol for displacing [3H]DAGO was ≈30 μM and that of 17β-estradiol was ≈ 200 μM. (2) What are the concentrations of the major steroid hormones in the brain's extracellular fluid? We have analyzed in 56 matched (i.e. simultaneously withdrawn) peripheral serum and cerebrospinal fluid (CSF) samples (from endocrinologically grossly normal patients) the concentrations of the unconjugated steroid hormones testosterone, androstendione, dehydroepiandrosterone (DHEA), progesterone and cortisol (all being more or less lipophilic) as well as those of their hydrophilic counterparts, i.e. DHEA-sulfate, or their hydrophilic binding proteins, i.e. sex hormone binding globulin, corticosterone binding globulin, and albumin. Total (i.e. free plus protein-bound) CSF levels of all these steroids were found to be in the 0.02–2 nM range except for cortisol (≈ 20–50 nM), thus 3 to 4 orders of magnitude lower than the IC50 of estrogens for [3H]DAGO (see above). These total CSF values were quite similar to the reported and calculated free serum levels of these steroids and no difference existed between those of patients with intact or with disturbed (abnormally leaky) blood-brain barrier function. Thus in vitro demonstrated low affinity (micromolar) interactions of steroids with neuronal membrane-bound receptors should be considered in view of the above found or expected concentrations of steroids in the interneuronal fluid. Whether neurosteroids can in vivo reach intrabrain concentrations of neuromodulatory efficacy remains to be seen; certain steroidal drugs, unlike peripheral steroid hormones, may do so.

References (63)

  • E.E. Baulieu

    Neurosteroids: a new function in the brain

    Biol. Cell. (Paris)

    (1991)
  • A. Munck et al.

    Specific and non-specific physicochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro

    J. Biol. Chem.

    (1968)
  • M. Beato

    Transcriptional control by nuclear receptors

    FASEB J.

    (1991)
  • B.S. McEwen et al.

    Steroid hormones: Humoral signals which alter brain cell properties and functions

    Rec. Prog. Horm. Res.

    (1982)
  • D.W. Pfaff et al.

    Action of estrogens and progestins on nerve cells

    Science

    (1983)
  • M.D. Majewska et al.

    Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

    Science

    (1986)
  • W.R. Martin

    Pharmacology of opioids

    Pharmac. Rev.

    (1984)
  • S.J. Paterson et al.

    Classification of opioid receptors

    Br. Med. Bull.

    (1983)
  • A. De Lean et al.

    Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves

    Am. J. Physiol.

    (1972)
  • H. Reiber

    The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid

    J. Neurol.

    (1980)
  • S. Schwarz et al.

    Hormone binding globulin levels in patients with hereditary angiooedema during treatment with Danazol

    Clin. Endocr. (Oxf.)

    (1981)
  • R. Faessler et al.

    Demonstration of sex hormone binding globulin in human cerebrospinal fluid

    Clin. Endocr. (Oxf.)

    (1985)
  • J. Predine et al.

    Protein binding of cortisol in human cerebrospinal fluid

    J. Clin. Endocr. Metab.

    (1984)
  • S. Schwarz

    Strategy and organization of intralaboratory radioimmunoassay quality control. Invited review paper

  • Parker L., Lifrak E., Shively J., Lee T., Kaplan B., Walker P., Calaycay J., Florsheim W. and Son-Shiong P.: Human...
  • E.M. Comford

    The blood-brain barrier, a dynamic regulatory interface

    Molec. Physiol.

    (1985)
  • K. Felgenhauer

    Protein size and cerebrospinal fluid composition

    Klin. Wschr.

    (1974)
  • J.H. Wood

    Neuroendocrinology of cerebrospinal fluid: Peptides, steroids, and other hormones

    Neurosurgery

    (1982)
  • S.I. Rapoport

    Passage of proteins from blood to cerebrospinal fluid. Model for transfer by pores and vesicles

  • W.P. Pardridge

    Receptor-mediated peptide transport through the blood-brain barrier

    Endocrine Rev.

    (1986)
  • R.D. Broadwell et al.

    Transcytotic pathway for blood-borne proteins through the blood-brain barrier

  • Cited by (44)

    • Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress

      2016, Brain Research
      Citation Excerpt :

      In support of this hypothesis, methamphetamine exposure and withdrawal has been reported to increase the permeability of the blood brain barrier to otherwise impermeable binding proteins (Kiyatkin and Sharma, 2012; Sharma and Ali, 2006). Furthermore, failure to show differences in bound steroid in the plasma, as in the current study, does not preclude increased binding protein in the cerebrospinal fluid (Schwarz and Pohl, 1994). It is therefore conceivable that chronic amphetamine exposure and withdrawal increases the permeability of the blood brain barrier to binding proteins such as CBG, which is known to play a critical role in maintaining a corticosterone pool accessible to central tissues following stress (Mattos et al., 2013).

    • Testosterone in the brain: Neuroimaging findings and the potential role for neuropsychopharmacology

      2013, European Neuropsychopharmacology
      Citation Excerpt :

      Additionally it has to be considered that the blood brain barrier is easily crossable for steroids due to their high lipid solubility. Correlations between free serum levels of DHEAS, androstendione and testosterone and levels measured within the cerebrospinal fluid (CSF) have been found (Schwarz and Pohl, 1992, 1994). Thus, testosterone has shown to act via nongenomic mechanisms in the brain (e.g., modulation of opioid receptors) (Schwarz et al., 1989).

    • Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways

      2011, Journal of Steroid Biochemistry and Molecular Biology
      Citation Excerpt :

      These other physiologic estrogens have long been labeled weak estrogens because they were tested exclusively via the genomic signaling pathway. Now we find that some of them (that have so far been tested) are actually quite potent via the nongenomic signaling pathway [29–32]. Their ability to act potently may relate to actions at particular life stages of women in which these hormones are quite prominent.

    View all citing articles on Scopus
    View full text